Pneumonia is still the leading cause of child mortality globally \[[@R1],[@R2]\]. However, an increased focus on the reduction of child mortality that arose from the United Nation\'s Millennium Declaration \[[@R3]\] and the Millennium Development Goal 4 has renewed the interest in developing more accurate estimates of the causes of child deaths. This should inform more effective health policies and track the progress of their impact. In 2001, the Child Health Epidemiology Reference Group (CHERG) -- a group of independent technical experts funded by The Gates Foundation and working closely with the World Health Organization (WHO) and UNICEF-- set out to systematically review and improve data collection, methods and estimates of the main causes of child deaths for 2000 \[[@R4]\]. Evidence from CHERG estimates -- ie, that pneumonia was the leading cause of child mortality --contributed to the initiation of a number of global efforts, such as the Global Action Plan for Pneumonia (GAPP). GAPP was designed to promote the expansion and improvement in community case management, the reduction in risk factors for disease and the support for the massive roll--out of vaccination against *Haemophilus influenzae* type b (Hib) and *Streptococcus pneumoniae* (SP) by countries through support from the GAVI Alliance \[[@R5],[@R6]\]. Those efforts, alongside economic and social developments observed in many low-- and middle--income countries over the past decade, have all contributed to a substantial reduction of the burden of morbidity and mortality from childhood pneumonia \[[@R7]\].

CHERG\'s work also led to several Lancet series that had a substantial impact on global, regional and national--level donors and policy--makers \[[@R7]--[@R10]\]. It also inspired similar efforts to address the epidemiology and provide estimates for other causes of the global burden of different diseases \[[@R11],[@R12]\]. The recent series of reviews published in the *Lancet* and *PLoS Medicine*, conducted by CHERG members in collaboration with the WHO, UNICEF and USAID within the Global Action Plan for Pneumonia and Diarrhoea (GAPPD), addressed the epidemiology and the current global burden of the two leading causes of childhood death, pneumonia and diarrhea, in the year 2010--11 \[[@R13]\]. The series also estimated the importance of risk factors \[[@R13]\], effectiveness of interventions \[[@R14]\], barriers to achieving high coverage at the community level \[[@R15]\], validity of coverage measures \[[@R16]--[@R17]\] and main implications for health policy \[[@R7]\].

The recent GAPPD reviews focused at the global and regional level \[[@R13]\]. The aim of this paper is to supplement the *Lancet*\'s GAPPD series with further information on the underlying models and methods, to augment that already available, and thereby assure that all input data and detailed descriptions of methods are transparently presented and available in an open--access source. Additionally, this paper also provides estimates of childhood pneumonia burden at the country level to allow national policy--makers and other stakeholders to implement the proposed policies in the World Health Organization (WHO) and UNICEF member countries.

Challenges to estimation of childhood pneumonia burden
======================================================

**Incidence and severe morbidity.** An accurate estimate of the global, regional and national burden of childhood pneumonia is very difficult to make for a number of reasons. First, the incidence of pneumonia can only be properly assessed through longitudinal community based studies \[[@R18]\]. Such studies are very scarce in low and middle--income countries, where the majority of the pneumonia disease burden occurs, in part because they require a major commitment from both the investigators and research funders in a low--resource setting over an extended period of time. Due to the seasonal nature of pneumonia incidence, which has various peaks in different seasons, studies measuring incidence need to be conducted over full calendar years (or multiple 12--month periods) \[[@R19]\]. The screening of large numbers of children needs to be active, regular and frequent (eg, no longer than 2 weeks between home visits), because recall bias leads to under--estimation especially in large families \[[@R19]\]. In addition to these basic methodological requirements, the most fundamental uncertainty with measuring the incidence of childhood pneumonia in a community setting comes from the choice of case definition and the accuracy of its application by the assessor who establishes the diagnosis. Since pneumonia is actually a diagnosis made on tissue pathology, there is no clinical definition that is fully accurate. In any community--based study on pneumonia incidence, the measured entity is not in fact childhood pneumonia itself, but rather the incidence of children who test positive for the chosen case definition of childhood pneumonia \[[@R20]\]. The case definition is based on a number of symptoms and signs; although the WHO definition of childhood pneumonia (cough or difficulty breathing and an elevated respiratory rate, defined according to the child's age) is the most frequently used in field studies, other definitions are often encountered in the literature confounding cross study comparisons of incidence. Depending on the combination of sensitivity and specificity of the chosen case definition, the burden of "true" pneumonia in the community of children can be grossly over-- or underestimated \[[@R20]\].

A further problem is that the clinical training of assessors differs between the studies and this often affects the application of case definitions, unless the study implementation is highly controlled. Physicians tend to use their own clinical judgment in addition to the case definition. They will be likely to provide more conservative estimates, while community health workers may over--diagnose pneumonia in a community to the level where they consider a high proportion of acute respiratory infections in a child as cases of "pneumonia" \[[@R19]\]. Moreover, it is important to understand for each study whether the investigators attempted to exclude cases of respiratory disease that met the clinical pneumonia case definition but were assessed in some other way as being bronchiolitis, pertussis, measles, or even asthma, malaria or neonatal sepsis.

The effect of these challenges was reflected in the first--ever attempt to estimate the incidence of childhood pneumonia, which identified only 28 studies that met the minimum quality criteria \[[@R18]\]. The incidence of pneumonia reported in these studies still ranged 100--fold between their minimum and maximum reported incidence rates per child--year which could reflect true heterogeneity in the burden of disease or more likely also reflects the challenges of standardizing the epidemiologic study design and its application at the field level \[[@R18]\]. Similar, if not greater problems are encountered with estimating the incidence of severe, life--threatening pneumonia (which requires hospital referral and treatment) in the community. This estimate cannot be based on measures of childhood pneumonia hospitalizations because parents' care seeking behavior, access to hospitals, and medical professionals' threshold for admission varies widely within and across geographic settings \[[@R19]\]. There are WHO definitions for severe pneumonia (cough and difficulty breathing with lower chest wall indrawing) and for very severe pneumonia (cough and difficulty breathing with danger signs). These definitions are useful insofar as they are applied at the community level for guiding the case management and referral of children to a hospital, hence are purposefully highly sensitive and poorly specific for truly life threatening disease. Therefore, estimates of the incidence of severe childhood pneumonia in the community are particularly rare. Moreover, great caution must be applied in making comparisons between studies or in combining data across studies to assure that only similarly designed and implemented case definitions are considered together. The best estimates of pneumonia usually come from the control arms of randomized controlled trials of vaccines. This is because severe pneumonia is usually an outcome that is being monitored over a multiple of 12 months, usually with a highly stipulated and rigorously implemented case definition. Such studies provide the best estimates of severe pneumonia in the community that we have today \[[@R19]\].

**Mortality.** Estimating mortality that results from childhood pneumonia in a community also has its significant methodological challenges. Mortality studies require similar study designs to incidence studies, although home visits do not need to be as frequent as in the former, because care--giver recall of a child death is more accurate and long--lasting than of an illness episode \[[@R21],[@R22]\]. Identifying the exact cause of death can be difficult in an appreciable number of cases. The assigned cause of death is usually based on a verbal autopsy provided by a mother or another family member. These are typically based on the report of signs and symptoms around the time of death. Many of them are not specific to pneumonia, but can also be found in children with other conditions, such as sepsis and malaria. In addition, many dying children have suffered from chronic malnutrition and may have other underlying ailments, such as asthma, metabolic disorders, immunodeficient conditions (HIV), sequelae of previous injuries, chronic diarrhea, or congenital defects \[[@R23]\]. They may develop pneumonia in addition to an exacerbation of another ailment, or have concomitant malaria or diarrhoea. In such cases, it is challenging to assign the death of a child to a single cause through verbal autopsy. Furthermore, the clinical signs and symptoms of a pneumonia death overlap with those of other causes of death such as malaria or measles, hence misclassification errors are significant. Moreover, there are studies that focus exclusively on pneumonia as a cause of death, while others are multi--cause mortality studies, documenting the causes of all child deaths in the community. Typically, studies focused exclusively on pneumonia tend to over--estimate its contribution to overall child mortality \[[@R24]\]. This is because in such studies it is more likely that a number of other underlying causes or immediate causes may be misclassified as pneumonia. Therefore, multi--cause mortality studies are preferred as a source of information to single--cause studies \[[@R24]\].

**Risk factors.** In addition to estimating the incidence, severe morbidity and mortality from childhood pneumonia at the global, regional and national level, it is important to understand risk factors that contribute to the development of childhood pneumonia and that may offer clues to prevention of the disease. However, well--conducted studies of pneumonia risk factors in low resource settings are remarkably scarce. There is wide variation among risk factor studies in their focus, study design and outcome: while some explore risk factors associated with incidence of pneumonia at the community level, others focus on the risks that are associated with progression to severe disease in those who already have pneumonia \[[@R1]\]. A third type of study are those that are hospital--based and investigate risk factors associated with progression to death in a child receiving treatment and compare case--fatality rates among different children \[[@R1]\].

Another methodological challenge is that the most commonly investigated risk factors for disease or for death are commonly identified together among cases. For example, undernutrition, use of solid fuels in a household, crowding, lack of exclusive breastfeeding, low degree of maternal education, limited access to secondary care and passive care--seeking behavior are all often characteristics of poor households, where most of the deaths occur. Because of this collinearity, an assessment of the effect size of any particular risk factor in isolation from the role of others will likely lead to gross over--estimation of the true effect size \[[@R1],[@R18],[@R19]\]. Therefore, very large prospective studies are required, based on multivariable study designs, to ensure an adequate number of study participants with heterogeneity in the prevalence of risk factors and thereby allow an accurate assessment of the individual role of each risk factor. Very few such studies exist; this is a permanent research priority, because the effect sizes attributable to individual risk factors in different contexts are still poorly understood \[[@R1],[@R18],[@R19]\].

**Etiological agents.** There is a growing need to identify etiological agents that contribute to the disease development at each of the three levels of severity -- episodes of community--acquired pneumonia (incidence), severe pneumonia (severe morbidity) and pneumonia deaths (mortality). This is because vaccines are now available to prevent infections with major pathogens, such and *Streptococcus pneumoniae* (SP), *Haemophilus influenzae type b* (Hib) and *influenza virus* (flu), while a vaccine against respiratory syncytial virus (RSV) is also being actively pursued \[[@R25]--[@R27]\]. However, precise estimation of the distribution of the episodes, severe episodes and deaths from childhood pneumonia by etiological agent is even more difficult than estimation of the overall disease burden itself, for a number of reasons. First and foremost, the site of infection -- the lung --is generally an inaccessible organ that is in constant contact with the external environment through the naso-- and oro--pharynx, which are body sites that are sampling and immunologically responding to potential pathogens. Second, the procedures needed to collect specimens from potential cases are ones that usually require a hospital facility, meaning that studies must be done in places where cases have access to a hospital facility. Such studies also require laboratory facilities that can process samples in a timely fashion and can run a multitude of tests to document presence of pathogens in a child \[[@R28]\]. This means that they tend to be (teaching) hospital--based and therefore do not sample across the whole range of pneumonia cases in a population. Most deaths from pneumonia occur in places where no hospital facility is available, highlighting the nearly inextricable paradox that appropriate studies cannot be done in the places where most of the death burden occurs.

Third, accepting that paradox, even in settings where studies can be done there are further issues. The choice of biological samples (specimen) in which the presence of a potential pathogen should be sought means that multiple body fluids must be collected. Ideally, for a bacterial diagnosis, samples should come from the lung tissue itself (eg, by needle aspirate), from a pleural exudate, or a blood culture sample, but this is often neither feasible nor acceptable in a professional or lay community \[[@R28]\]. As an alternative, analyses of collected sputum or nasopharyngeal swabs can be performed, but their contribution to understanding the etiology is complex since the pathogens identified in these locations are also commonly found among healthy children.

Fourth, the more tests performed, the more agents will be found, and statistical methods to disaggregate and associate individual pathogen contributions to etiology are lacking. This is an increasing problem with modern sensitive techniques like PCR--based tests identifying the presence of often many co--existing and potentially pathogenic agents (whose role in the disease episode is very uncertain). Finally, we don\'t sufficiently understand the interplay between various pathogens and how a specific time sequence (eg, a viral infection, followed by a bacterial superinfection) may act to compromise the local and/or systemic immune response to cause a serious and life--threatening episode of childhood pneumonia by a pathogen that may otherwise not cause severe disease. Even with sophisticated expansive testing a significant proportion of cases may not have an etiology associated with the case. The meaning of this has to be assessed. Some of these cases may not have pneumonia at all, while other cases may not be associated with an etiology because of statistical methods used, in spite of identification of pathogens in the upper respiratory tract; finally, some may not be assigned to a causal pathogen because of laboratory test insensitivity. There remains therefore a gap in understanding the etiological spectrum of what is clinically defined as pneumonia \[[@R25],[@R28]\].

These complex issues for studying pneumonia etiology are being addressed in a large, 7 country pneumonia etiology study among children (PERCH) \[[@R25]\]. This study is under way and the first results are expected following the completion of the field work (in early 2014) and an analysis period.

Because of the many biologic, epidemiologic, laboratory, and statistical challenges of pneumonia etiology observational studies, the most reliable methods for estimation of the proportional contribution of different pathogens to the burden of childhood pneumonia are vaccine trials \[[@R29]\]. The observed reduction in the incidence of pneumonia (using various case definitions) following vaccination reveals the disease burden attributable to that specific pathogen, once the less than 100% vaccine efficacy of the product is accounted for. This approach also has its limitations, mostly insofar as a vaccine trial can only reveal the burden of one pathogen at a time. For some pathogens (such as SP), not all disease--causing strains may be included in a strain specific vaccine \[[@R30]\]. If the distribution of strains varies by factors that also contribute to variation in pneumonia disease burden (eg, geography, pneumonia case definition, malnutrition, HIV), then careful attention must be paid to applying the vaccine efficacy measures to the appropriate measure of pneumonia disease burden \[[@R29]\]. Also, vaccine--based approach may be very useful in understanding the causal contribution at the level of incidence and severe morbidity, but may be limited in their ability to inform about the pathogen contribution to mortality (which is often a rare event in vaccine trials, where enormous resources are in place that themselves reduce the risk of death). Finally, although it might be ideal to conduct vaccine trials in parallel in many geographic regions using a harmonized protocol to reveal the geographic variability in contribution of pathogens to disease, vaccine trials are not usually designed for the purpose of disease burden estimation; they are also very expensive to conduct, which limits the number of sites where they can be undertaken \[[@R31]\]. They are generally not sufficiently large to have acceptable statistical power to detect a mortality reduction, as there are relatively few deaths in the study population.

Moreover, after a definite proof of vaccine efficacy and effectiveness is established, there are significant ethical issues regarding the conduct of further trials if they necessitate a control arm in which children are not provided what has been shown to be a life--saving vaccine. This self--limits the accumulation of the evidence towards the importance of specific pathogens. An additional layer of complexity comes from the notion that the etiological spectrum may change markedly with increasing severity of disease: at the level of incidence of childhood pneumonia in the community, viral causes seem to be responsible for a majority of episodes. However, a proportion of these cases will result in severe and life--threatening disease. In a sub--sample of severe cases, bacterial agents seem to be over--represented. Evidence from antibiotic treatment trials, from vaccine trials, and from studies of lung puncture studies provide a firm evidence base that episodes of death from pneumonia are dominated by bacterial causes. If true, this would suggest that SP and Hib vaccine probe studies (with "proxy" endpoints of severe episodes prevented) may under--estimate the importance of these agents as a cause of death. Longitudinal studies of mortality in low--income countries that have introduced Hib and SP vaccines recently and that are achieving high vaccine coverage will likely provide confirmatory evidence of that contribution to pneumonia mortality in the coming years \[[@R25],[@R26],[@R31]\].

An overview of previous estimates
=================================

One of the earliest attempts at estimating the global burden of communicable diseases was provided by Cockburn and Assaad in the early 1970s \[[@R32]\]. Bulla and Hitze built on their work by specifically addressing the contribution of acute respiratory infections \[[@R33]\]. Almost a decade later, Leowski \[[@R34]\] used data from 39 countries to estimate that acute respiratory infections may have been causing about 4 million child deaths each year: 2.6 million in infants and further 1.4 million in children aged 1--4 years. In the early 1990s Garenne et al. \[[@R35]\] further refined these estimates using an epidemiological model that explored the association between all--cause child mortality and the proportion of deaths attributable to acute respiratory infections, showing that between 20--33% of child deaths were associated with respiratory infections \[[@R35],[@R36]\].

The 21^st^ century has seen a much larger number of efforts, mainly designed and led by CHERG and their partners, which further improved the understanding of the epidemiology and etiology of childhood pneumonia. The first estimate of global incidence of childhood pneumonia was provided by Rudan et al. \[[@R18]\] for 2000. In parallel, a refined estimate of childhood pneumonia mortality for the same year, based mainly on single--cause studies, was provided by Williams et al. \[[@R37]\]. The first estimate of pneumonia mortality from multi--cause studies was published by Black et al. in CHERG\'s paper on the causes of global child mortality in the year 2000 \[[@R4]\]. Then, estimates underwent further refinements and updates. An updated estimate of childhood pneumonia mortality for 2008 in post--neonatal children in low and middle--income countries, based on single--cause studies, was provided by Theodoratou et al. \[[@R38]\]. Estimates based on multi--cause studies underwent three updates: for the period 2000--2003 by Bryce et al. \[[@R39]\]; for 2008 by Black et al. \[[@R40]\]; and for 2010 by Li et al. \[[@R41]\].

The first comprehensive assessment of the burden of severe pneumonia according to the WHO\'s definition and the role of risk factors was provided by Rudan et al. \[[@R1],[@R18]\]. This work was followed by the first attempt to estimate the global burden of childhood pneumonia on health systems; Nair et al. \[[@R42]\] used both published and unpublished information to calculate the number of hospitalizations for severe pneumonia, a number which is smaller than the estimate of cases of severe pneumonia in the community because of lack of access and/or care--seeking in many settings.

Once the "envelopes" for the burden of pneumonia incidence, severe morbidity and mortality from pneumonia in 2000 were provided, a series of efforts attempted to estimate the proportion of the burden at each level of severity that can be attributed to the main etiological agents that cause pneumonia. O\'Brien et al. \[[@R43]\] developed the first global, regional and country estimates for the morbidity and mortality from *Streptococcus pneumoniae*, Watt et al. for *Haemophilus influenzae* type b \[[@R44]\], while Nair et al. generated global and regional estimates for RSV \[[@R45]\] and for influenza \[[@R46]\].

The estimates of pneumonia incidence, severe pneumonia cases, severe pneumonia hospitalizations, pneumonia mortality, and cause specific estimates are based on different and almost entirely independent sources of information, which allows for assessments of validity and consistency between the various estimates. Validation of these estimates can be approached in various ways. A few examples include: (i) an assessment of the measured proportion of all pneumonia cases that are categorized as severe; (ii) the ratio between the estimates of severe episodes and deaths, and also (iii) between all pneumonia episodes and deaths. These proportions and ratios need to largely support the observed case--fatality rates typically seen in both community--based and hospital--based data sets from individual studies. Moreover, the sum of etiology specific fractions attributed to different pathogens needs to fit within the overall burden of incidence, severe morbidity and mortality. For the Hib and pneumococcal pathogen specific estimates, they must fit within these envelopes by definition, since the methodology to estimate the absolute burden was a proportional approach -- but this was not the approach for the estimation of the RSV or influenza burden. The ratios between different pathogens were also found to broadly reflect those observed in the high quality field studies or hospital--based studies further validating the estimates. Towards the end of the past decade it was notable that, regardless of all methodological challenges and uncertainty inherent to this research, all the major estimates from different sources were increasingly consistent with each other and provided a clearer global and regional picture of the burden of childhood pneumonia and its causing pathogens, albeit with wide uncertainty bounds around the point estimates \[[@R40]--[@R46]\]. This paper therefore brings all the estimates together and provides an update for 2010--11, in which all information is provided in a single analysis, and where country--level estimates are also be provided.

METHODS
=======

Many steps are required to develop an internally consistent estimate of global, regional and national burden of childhood pneumonia based on best available evidence. To fully explain our approach, we developed a table (Online Supplementary Document[(Online Supplementary Document)](#S1){ref-type="supplementary-material"}) which all input data, assumptions, methods, solutions to specific problems or dilemmas, formulae for calculation of different parameters, and the interim and final estimates are provided. In this section, we present a summary for those steps, list all sources of data and explain the rationale for each subsequent step.

Input data for country--level populations and prevalence of risk factors for pneumonia incidence
================================================================================================

Initially, we list 192 countries by World Health Organization\'s regional classification, with 6 main regions (the Americas (AMRO), Africa (AFRO), Eastern Mediterranean region (EMRO), European region (EURO), Western Pacific region (WPRO) and South--East Asian region (SEARO)) and further divisions by the level of development into "A", "B", "C", "D" and "E" sub--regions \[[@R47]\]. For each country, an estimate of the population of children under the age of 5 years in 2010 was obtained from the UN\'s Population Division \[[@R48]\]. Then, the 5 most important risk factors for childhood pneumonia incidence were identified. They were selected based on consistently significant effects in multivariate study designs and previous meta--analyses \[[@R1],[@R18]\]. They are: malnutrition (weight--for--age z\<--2), low birth weight (≤2500 g), non--exclusive breastfeeding (in the first 4 months), solid fuel use ("yes") and crowding (7 or more persons sharing the same household) \[[@R1],[@R18]\]. The data on the prevalence of exposure to each of those 5 risk factors in each country in the year 2010(or the closest year with available data) was obtained from the recent Demographic and Health Surveys (DHS) and Multiple Indicator Cluster Surveys (MICS) \[[@R49],[@R50]\]. For all countries in which data on the prevalence of exposure were not available, the prevalence was imputed based on the regional mean value, which was weighted by population size of all countries with any data. The effect size of each risk factor on pneumonia incidence was assessed through meta--analysis of the studies that reported multivariable analyses of risk factor\'s odds ratios (OR) in low and middle--income countries. The meta--estimates of odds ratios assigned to each risk factor were: 1.8 for malnutrition, 1.4 for low birth weight, 1.3 for non--exclusive breastfeeding, 1.8 for use of solid fuels and 2.0 for crowding. In high--income countries, where less than 2% of all cases of community--acquired pneumonia occur, we did not use the model based on risk factors but rather applied "flat" rates of incidence for "A", "B" and "C" regions based on several high--quality studies (see Online Supplementary Document[(Online Supplementary Document)](#S1){ref-type="supplementary-material"}), and which ranged between 0.015 and 0.060 episodes/child--year (see later). For the proportion of severe episodes in each high--income region we used one single rate which was the median of all available studies (26.7%, see later).

Computation of country--level incidence of pneumonia and severe pneumonia
=========================================================================

In all LMIC countries, we multiplied the number of children in each country by the prevalence of exposure to each of the 5 risk factors. This provided an estimate of the absolute number of exposed children in each country who were at excess risk of developing childhood pneumonia in the year 2010. We then calculated the proportion (ie, a weighted mean) of all children in each LMIC region and country exposed to each of the 5 risk factors; then, in each country, we multiplied the proportion of children who were above, or below, the regional exposure level with the meta--estimate of the odds ratio attributable to each of the 5 risk factors.

The number of pneumonia cases in each low and middle--income country (LMIC) was calculated using a model based on the epidemiological concept of potential impact fraction \[[@R51]\], as follows:
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where N is the number of new episodes of childhood pneumonia per year in each country, Pop~\<5yrs~is the population of children aged 0--4 years in each LMIC, Inc~LMIC~ is the estimated incidence of clinical pneumonia for all LMIC, Prev~RFn~ is the prevalence of exposure to *n*--th risk factor among those under 5-year in the country of interest, Prev~RFnLMIC~ is the prevalence of exposure to *n*^th^ risk factor among under--fives in all LMIC, and RR~RFn~ is the relative risk for developing clinical pneumonia associated with the *n*^th^ risk factor (see Online Supplementary Document[(Online Supplementary Document)](#S1){ref-type="supplementary-material"} for further details).

The incidence of pneumonia for all LMIC was derived from35 community--based studies published between1990 and 2012 (references shown in Online Supplementary Document[(Online Supplementary Document)](#S1){ref-type="supplementary-material"}), by using the median value (0.22 episodes/child--year) and inter--quartile range (IQR) 0.11--0.51 as confidence intervals.

Although there are many possible methods to distribute the global and/or regional burden estimate among individual countries, the approach used above is our preferred solution because it is epidemiologically sound and biologically intuitive insofar as it is based on the country specific prevalence of known risk factors for pneumonia, and because it can be explained in a transparent and accessible manner. Although more complex models exist, our experience is that these sometimes result in implausibly high or low estimates for some countries, the cause of which is difficult to disentangle. This model, because of its computational simplicity and epidemiologic basis, has not suffered from this problem. The model has also been shown to distribute a known overall burden by specific countries in the absence of truly nationally representative information from many (or, in this case, from most) countries in a way which is consistent with clinical and epidemiologic knowledge.

The proportion of cases of severe pneumonia (based on the WHO definition that requires presentation of lower chest wall indrawing, and represents an indication for hospitalization) for LMIC was computed based on 9 community--based studies in LMIC that reported the proportion of severe pneumonia episodes among all pneumonia episodes (references shown in Online Supplementary Document[(Online Supplementary Document)](#S1){ref-type="supplementary-material"}). The median value was 11.5% (IQR 8.0--33.0%). The incidence of pneumonia in high--income countries, based on a smaller number of very large, high--quality studies (references shown in Online Supplementary Document[(Online Supplementary Document)](#S1){ref-type="supplementary-material"}), was also estimated using medians (and IQR): it was 0.015 e/cy in EUROA and AMROA regions; 0.030 e/cy in EURO Band 0.060 in EURO C. The mean of those values (for the whole HIC region), weighted by their under--five population size, was0.024 e/cy \[[@R52]\]. Approximately 26.7% (IQR 20.0--46.7%) of those episodes are estimated to progress to severe pneumonia, based on several studies from high--income countries (references shown in Online Supplementary Document[(Online Supplementary Document)](#S1){ref-type="supplementary-material"}). The estimates for the number of incident and severe pneumonia episodes derived in this way did not account for the use and effect of pneumococcal conjugate vaccine (PCV) and Hib vaccination coverage in 2010 at this stage of the estimation process, so the values from this step are not considered the final pneumonia burden numbers.

Etiologic fractions of pneumonia and severe pneumonia cases
-----------------------------------------------------------

We split both the incidence and severe morbidity of childhood pneumonia by etiological agents while adjusting for the effects PCV and Hib vaccines according to country specific coverage values provided for 2010 by the UNICEF \[[@R53]\]. In doing so, we used the proportional contributions to all childhood pneumonia and severe childhood pneumonia from previous burden estimates on SP \[[@R43]\], Hib \[[@R44]\], RSV \[[@R45]\] and influenza \[[@R46]\] and accounted for vaccine efficacy and serotype distribution of pneumococcal disease as well as dual use of Hib and PCV where relevant. All further details are available in Online Supplementary Document[(Online Supplementary Document)](#S1){ref-type="supplementary-material"}.

Country--specific estimates of the number of deaths from childhood pneumonia
----------------------------------------------------------------------------

This was available for 2010 from Li et al. \[[@R41]\]. A more recent update was made available by the UN Inter--Agency Group for Child Mortality Estimation IGME in UNICEF\'s 2012 report, which we term a "2010--2011" estimate \[[@R54]\]. Given the important focus on child mortality, and relatively minor differences compared with the Li 2010 estimates, we elected to use the 2010--11estimates for the envelopes of pneumonia deaths by country. The same decision was made in the Lancet\'s series \[[@R13]\]. The only methodological problem with this decision is a separation of Sudan and introduction of the new country -- South Sudan from 2011, but we presented our results on mortality for both Sudan nations combined, and kept it within the EMRO region, although South Sudan belongs to AFRO region in the new classification \[[@R47]\].

Proportional split of pneumonia deaths by etiological agent
-----------------------------------------------------------

To estimate the fraction of pneumonia deaths attributable to SP and Hib, we used the meta--analysis of the efficacy of PCV and Hib vaccines against chest X--ray confirmed pneumonia as has been described earlier (43,44), based on the assumption that the etiologic fraction of these bacteria among these particular cases approximates the etiologic fraction among the deaths. The values (33.0% for SP and 21.3% for Hib) were then adjusted by country for the use of PCV and Hib vaccine to derive the final SP and Hib proportions \[[@R43],[@R44],[@R53]\]. Since the global disease burden estimates for flu and RSV pneumonia were not able to give point estimates and confidence intervals due to lack of data we did not attempt to go beyond the published global and regional estimates for these conditions and so did not attempt to derive national--level estimates \[[@R45],[@R46]\].

RESULTS
=======

[**Table 1**](#T1){ref-type="table"} presents our estimates for 192 countries, grouped by the WHO regions: Africa (AFRO), the Americas (AMRO), Eastern Mediterranean region (EMRO), South--East Asian region (SEARO), Western Pacific region (WPRO) and European region (EURO). Several main results emerge from the presented figures. First, the population of under--five children in the world increased from 604.9 million to 633.5 million between 2000 and 2010, but the majority of the increase was observed in low-- and middle--income countries (523.3 to 547.3 million), and only a smaller share in high--income countries (81.6 to 86.2 million). Holding all else constant, an increase in total child population would increase the absolute number of pneumonia cases; however, the number of cases has decreased over the past decade, because the incidence has decreased substantially. When presenting our estimates of incidence for 2000, we reported on 28 studies published between 1960 and 2000 that suggested an estimated incidence of 0.29 (0.21--0.71) episodes per child--year globally \[[@R18]\]. In this most recent estimate, we used 35 studies published between 1990 and 2010 with a median incidence of 0.22 (0.11--0.51). This is a notable reduction, of nearly 25%, over a period of a decade. In high--income countries we gathered more data over the past decade, and a very rough estimate of 0.05 e/cy, based on two very large, but historic studies in the USA and the UK \[[@R55],[@R56]\], was refined and replaced with the data from 9 more contemporary studies, which provide a community--based incidence of 0.015 e/cy (0.012--0.020) for HIC only (WHO\'s "A" regions), a more plausible estimate for the modern industrial societies.

###### 

Estimates of the number of new episodes (incidence) of community--acquired pneumonia in 2010 in children 0--4 years of age in 192 countries, shown as national--level totals (incidence, all ALRI) and by causative pathogens (SP, Hib, RSV and flu); estimates of the number of new severe episodes (according to WHO\'s definition) in the year 2010 that require hospitalizations, shown as national--level totals (severe episodes, all ALRI) and by causative pathogens (SP, Hib, RSV and flu); and estimates of the number of child deaths attributable to pneumonia in 2011 (mortality, all ALRI) and the proportion of deaths caused by SP and Hib

                                                                      New episodes (incidence)   New severe episodes (severe morbidity)   Deaths (mortality)                                                                                                                
  ---------------------- ---------------- --------------------------- -------------------------- ---------------------------------------- -------------------- ---------- --------- -------------- -------- --------- --------- --------- -------------- -------- --------- ----------------
  **Country**            **WHO Region**   **Population 0--4 years**   **All ALRI**               **SP**                                   **Hib**              **RSV**    **FLU**   **All ALRI**   **SP**   **Hib**   **RSV**   **FLU**   **All ALRI**   **SP**   **Hib**   **RSV, FLU\***
  **AFRO REGION**                                                                                                                                                                                                                                                           
  Algeria                AfroD            3446548                     470713                     34251                                    4697                 135754     80351     53790          10297    783       7315      2251      2440           804      148       N/A
  Angola                 AfroD            3377576                     856794                     62241                                    9674                 247099     146255    97936          18712    1613      13293     4090      20429          6733     1398      N/A
  Benin                  AfroD            1506408                     424074                     30705                                    5895                 122303     72389     48501          9231     983       6558      2018      6281           2070     522       N/A
  Burkina Faso           AfroD            2955148                     1047365                    76085                                    11826                302060     178785    119719         22874    1972      16250     5000      17933          5911     1227      N/A
  Cameroon               AfroD            3054802                     790160                     56858                                    14815                227882     134880    90462          17094    2470      12143     3736      13341          4397     1463      N/A
  Cape Verde             AfroD            50634                       9874                       691                                      395                  2848       1686      1136           208      66        148       45        39             13       8         N/A
  Chad                   AfroD            2006165                     678297                     48155                                    19812                195621     115785    77827          14477    3304      10285     3164      14683          4840     2390      N/A
  Comoros                AfroD            122296                      38380                      2769                                     645                  11069      6552      4392           832      108       591       182       377            124      37        N/A
  Equ. Guinea            AfroD            107207                      16341                      1144                                     654                  4713       2789      1879           344      109       244       75        402            132      85        N/A
  Gabon                  AfroD            185179                      36186                      2579                                     943                  10436      6177      4149           775      157       551       170       291            96       43        N/A
  Gambia                 AfroD            287078                      79805                      2667                                     802                  23016      13623     8746           802      134       1338      412       987            171      56        N/A
  Ghana                  AfroD            3532887                     795448                     57857                                    8199                 229407     135783    90905          17394    1367      12357     3802      7808           2573     490       N/A
  Guinea                 AfroD            1657883                     546525                     39262                                    10948                157618     93292     62586          11804    1826      8385      2580      7689           2534     895       N/A
  Guin.--Bissau          AfroD            240350                      75199                      5429                                     1216                 21687      12836     8605           1632     203       1159      357       1592           525      152       N/A
  Liberia                AfroD            680701                      212990                     15195                                    5418                 61426      36357     24419          4568     903       3245      999       1611           531      232       N/A
  Madagascar             AfroD            3305278                     1051407                    76189                                    13932                303226     179475    120231         22906    2323      16272     5007      8004           2638     637       N/A
  Mali                   AfroD            2911668                     932894                     67350                                    15086                269047     159245    106745         20248    2516      14384     4426      23947          7893     2292      N/A
  Mauritania             AfroD            513267                      144982                     10415                                    2904                 41813      24748     16603          3131     484       2224      684       2099           692      244       N/A
  Mauritius              AfroD            84433                       13518                      985                                      117                  3899       2307      1544           296      20        210       65        20             7        1         N/A
  Niger                  AfroD            3084517                     1127652                    81210                                    20418                325215     192490    129082         24415    3405      17344     5337      19004          6264     2018      N/A
  Nigeria                AfroD            26568927                    7339761                    513783                                   293590               2116787    1252897   844072         154465   48956     109729    33763     121201         39948    25767     N/A
  S. Tome & P\'e         AfroD            23490                       5118                       373                                      46                   1476       874       585            112      8         80        25        79             26       4         N/A
  Senegal                AfroD            2081483                     591373                     42853                                    7836                 170552     100947    67625          12883    1307      9152      2816      4612           1520     367       N/A
  Seychelles             AfroD            5623                        862                        63                                       7                    248        147       98             19       1         13        4         2              1        0         N/A
  Sierra Leone           AfroD            969597                      315676                     22866                                    4286                 91041      53886     36101          6874     715       4883      1503      7262           2393     591       N/A
  Togo                   AfroD            862745                      280487                     20292                                    4082                 80893      47879     32083          6101     681       4334      1333      3321           1095     288       N/A
  Zimbabwe               AfroD            1692247                     349031                     25271                                    4852                 100661     59580     39918          7598     809       5397      1661      2461           811      205       N/A
  Botswana               AfroE            225120                      47818                      3347                                     1913                 13791      8162      5499           1006     319       715       220       159            52       34        N/A
  Burundi                AfroE            1184632                     349477                     25440                                    3373                 100789     59656     39933          7648     562       5433      1672      7259           2393     428       N/A
  Cen. Afr. Rep.         AfroE            651222                      195417                     13981                                    4538                 56358      33358     22394          4203     757       2986      919       3911           1289     520       N/A
  Congo                  AfroE            623244                      168619                     12244                                    1959                 48630      28783     19275          3681     327       2615      805       2001           659      141       N/A
  Cote d\'Ivoire         AfroE            2969425                     985611                     71421                                    13060                284250     168244    112707         21472    2178      15253     4693      11003          3626     875       N/A
  D. Rep. Congo          AfroE            11848026                    3671614                    263117                                   80589                1058894    626745    420631         79104    13438     56194     17291     86897          28641    10986     N/A
  Eritrea                AfroE            861496                      208035                     15163                                    1802                 59997      35512     23766          4559     301       3238      996       2419           797      129       N/A
  Ethiopia               AfroE            11931668                    3367561                    240540                                   82471                971205     574843    386005         72317    13752     51372     15807     37269          12284    5196      N/A
  Kenya                  AfroE            6664323                     1645189                    119118                                   22871                474473     280834    188157         35812    3814      25440     7828      17064          5624     1419      N/A
  Lesotho                AfroE            274307                      58335                      4224                                     811                  16824      9958      6672           1270     135       902       278       607            200      50        N/A
  Malawi                 AfroE            2714859                     658512                     47877                                    7004                 189915     112408    75261          14394    1168      10225     3146      6932           2285     448       N/A
  Mozambique             AfroE            3876419                     1155781                    83373                                    19438                333327     197292    132266         25065    3241      17806     5479      13167          4340     1307      N/A
  Namibia                AfroE            286374                      63796                      4619                                     887                  18399      10890     7296           1389     148       987       304       287            95       24        N/A
  Rwanda                 AfroE            1830654                     397910                     13638                                    3991                 114757     67923     43646          4100     666       6659      2049      4145           734      236       N/A
  South Africa           AfroE            5041132                     705554                     33436                                    14342                203482     120438    78749          10052    2392      11357     3494      5156           1218     583       N/A
  Swaziland              AfroE            156715                      28802                      2091                                     344                  8306       4916      3293           629      57        446       137       471            155      34        N/A
  Uganda                 AfroE            6465275                     1745727                    126241                                   25969                503468     297996    199697         37953    4330      26961     8296      21181          6981     1876      N/A
  U. R. Tanzania         AfroE            8009544                     2151379                    156285                                   24291                620458     367240    245913         46986    4051      33378     10270     17467          5757     1195      N/A
  Zambia                 AfroE            2412190                     576056                     41709                                    8008                 166135     98333     65882          12539    1335      8908      2741      6141           2024     511       N/A
  **AMRO REGION**                                                                                                                                                                                                                                                           
  Canada                 AmroA            1884546                     25275                      866                                      271                  13709      8032      6438           604      105       3774      755       27             5        2         N/A
  Cuba                   AmroA            569056                      8208                       598                                      79                   4452       2609      2178           417      31        1140      228       63             21       4         N/A
  USA                    AmroA            21650217                    313322                     22733                                    3845                 169946     99574     83169          15868    1489      43355     8671      799            263      59        N/A
  Antigua & B\'a         AmroB            7756                        686                        50                                       6                    198        117       78             15       1         41        8         0              0        0         N/A
  Argentina              AmroB            3385831                     311588                     22663                                    3212                 89862      53188     35609          6814     536       18616     3723      952            314      60        N/A
  Bahamas                AmroB            25507                       2514                       182                                      23                   725        429       287            55       4         151       30        25             8        1         N/A
  Barbados               AmroB            14562                       1377                       60                                       19                   397        235       153            18       3         87        17        4              1        0         N/A
  Belize                 AmroB            36599                       4795                       349                                      46                   1383       819       548            105      8         287       57        9              3        1         N/A
  Brazil                 AmroB            15156449                    1497706                    95518                                    14711                431938     255658    169535         28717    2453      91150     18230     3079           916      181       N/A
  Chile                  AmroB            1219437                     88722                      6448                                     973                  25588      15145     10141          1938     162       5296      1059      145            48       10        N/A
  Colombia               AmroB            4497661                     488486                     31421                                    6092                 140879     83385     55372          9446     1016      29585     5917      1530           459      113       N/A
  Costa Rica             AmroB            362979                      37185                      1272                                     425                  10724      6348      4080           382      71        2389      478       24             4        2         N/A
  Dominica               AmroB            5924                        703                        51                                       6                    203        120       80             15       1         42        8         0              0        0         N/A
  Dominican R.           AmroB            1054063                     121820                     8813                                     1773                 35133      20795     13934          2650     296       7239      1448      587            193      51        N/A
  El Salvador            AmroB            616802                      72388                      3616                                     829                  20877      12357     8079           1087     138       4515      903       221            54       15        N/A
  Grenada                AmroB            9687                        1021                       74                                       10                   295        174       117            22       2         61        12        0              0        0         N/A
  Guyana                 AmroB            64818                       7186                       523                                      72                   2072       1227      821            157      12        429       86        19             6        1         N/A
  Honduras               AmroB            966002                      184407                     13435                                    1658                 53183      31478     21068          4039     277       11036     2207      478            157      26        N/A
  Jamaica                AmroB            246543                      31065                      2264                                     269                  8959       5303      3549           681      45        1860      372       104            34       6         N/A
  Mexico                 AmroB            11094854                    1110027                    40375                                    11872                320132     189482    122060         12138    1980      71108     14222     4069           759      248       N/A
  Panama                 AmroB            345142                      38834                      2112                                     415                  11200      6629      4354           635      69        2404      481       128            33       8         N/A
  Paraguay               AmroB            740282                      139661                     10141                                    1623                 40278      23840     15965          3049     271       8330      1666      368            121      26        N/A
  St. Kitts & N\'s       AmroB            4582                        441                        32                                       4                    127        75        50             10       1         26        5         0              0        0         N/A
  Saint Lucia            AmroB            15115                       1492                       109                                      14                   430        255       170            33       2         89        18        0              0        0         N/A
  St. Vinc. & G\'s       AmroB            9254                        967                        70                                       8                    279        165       110            21       1         58        12        1              0        0         N/A
  Suriname               AmroB            47543                       6578                       477                                      85                   1897       1123      752            143      14        392       78        20             7        2         N/A
  Trinidad & Tobago      AmroB            95484                       9784                       710                                      114                  2822       1670      1118           214      19        584       117       38             13       3         N/A
  Uruguay                AmroB            246446                      17570                      647                                      188                  5067       2999      1933           194      31        1125      225       53             10       3         N/A
  Venezuela              AmroB            2926202                     308502                     22291                                    4789                 88972      52661     35295          6702     799       18310     3662      927            305      85        N/A
  Bolivia                AmroD            1234922                     137114                     9915                                     2040                 39544      23405     15685          2981     340       8145      1629      1909           629      169       N/A
  Ecuador                AmroD            1469919                     163860                     10901                                    1437                 47257      27971     18596          3277     240       9934      1987      712            219      38        N/A
  Guatemala              AmroD            2167408                     481781                     35042                                    4966                 138946     82240     55058          10535    828       28785     5757      2012           663      126       N/A
  Haiti                  AmroD            1237203                     345081                     24156                                    13803                99521      58905     39684          7262     2302      19842     3968      4090           1348     870       N/A
  Nicaragua              AmroD            677569                      141434                     10304                                    1272                 40790      24143     16159          3098     212       8464      1693      503            166      28        N/A
  Peru                   AmroD            2909336                     313170                     12566                                    3545                 90318      53458     34584          3778     591       19904     3981      1040           211      67        N/A
  **EMRO REGION**                                                                                                                                                                                                                                                           
  Bahrain                EmroB            93006                       9763                       327                                      91                   2816       1667      1070           98       15        227       101       5              1        0         N/A
  Cyprus                 EmroB            63553                       7253                       528                                      70                   2092       1238      829            159      12        156       69        1              0        0         N/A
  Iran (Isl. Rep.)       EmroB            6149331                     729564                     51069                                    29183                210406     124537    83900          15354    4866      15102     6712      4168           1374     886       N/A
  Jordan                 EmroB            816013                      87843                      6400                                     790                  25334      14995     10036          1924     132       1893      841       268            88       15        N/A
  Kuwait                 EmroB            281414                      29357                      994                                      284                  8467       5011      3218           299      47        681       303       38             7        2         N/A
  Lebanon                EmroB            321684                      35518                      2569                                     517                  10243      6063      4063           773      86        760       338       49             16       4         N/A
  Libyan A. J.           EmroB            715540                      80748                      5883                                     726                  23288      13784     9225           1769     121       1740      773       60             20       3         N/A
  Oman                   EmroB            281883                      32111                      1074                                     300                  9261       5481      3518           323      50        746       332       25             4        1         N/A
  Qatar                  EmroB            90524                       9669                       331                                      97                   2788       1650      1061           100      16        224       100       4              1        0         N/A
  Saudi Arabia           EmroB            3145187                     337985                     11445                                    3273                 97475      57694     37052          3441     546       7842      3485      372            65       20        N/A
  Syrian A. R.           EmroB            2493561                     280849                     20309                                    4178                 80997      47941     32127          6106     697       6006      2669      572            189      51        N/A
  Tunisia                EmroB            868231                      99837                      6989                                     3993                 28793      17042     11481          2101     666       2067      919       209            69       44        N/A
  U. A. Emir.            EmroB            420630                      46752                      1660                                     517                  13483      7981      5137           499      86        1079      480       14             3        1         N/A
  Afghanistan            EmroD            5545968                     2040302                    146694                                   39565                588423     348280    233617         44102    6598      43379     19280     30913          10189    3494      N/A
  Djibouti               EmroD            113169                      24926                      1808                                     306                  7189       4255      2850           544      51        535       238       446            147      33        N/A
  Egypt                  EmroD            9008118                     680363                     47625                                    27215                196217     116138    78242          14318    4538      14084     6259      4765           1570     1013      N/A
  Iraq                   EmroD            5188175                     893131                     62519                                    35725                257579     152457    102710         18796    5957      18488     8217      7568           2494     1609      N/A
  Morocco                EmroD            3021924                     385554                     27959                                    3343                 111194     65814     44029          8406     557       8316      3696      3103           1019     165       N/A
  Pakistan               EmroD            21418111                    6728235                    487755                                   86960                1940423    1148510   769337         146640   14501     144236    64105     64853          21376    5039      N/A
  Somalia                EmroD            1667479                     650669                     45547                                    26027                187653     111069    74827          13693    4340      13469     5986      18089          5962     3846      N/A
  Sudan                  EmroD            6391368                     2061300                    148754                                   34001                594479     351864    235876         44722    5670      43989     19550     26894          8864     3681      N/A
  Yemen                  EmroD            4057096                     1150463                    83436                                    14494                331793     196384    131540         25084    2417      24673     10966     15193          5008     1152      N/A
  **SEARO REGION**                                                                                                                                                                                                                                                          
  Indonesia              SearoB           21578876                    3918360                    274285                                   156734               1130055    668864    450611         82462    26135     99135     22531     19147          6311     4071      N/A
  Sri Lanka              SearoB           1892699                     433688                     31610                                    3757                 125076     74030     49545          9503     626       11425     2597      298            98       16        N/A
  Thailand               SearoB           4360687                     648021                     45361                                    25921                186889     110617    74522          13638    4322      16395     3726      903            298      192       N/A
  Timor Leste            SearoB           192839                      67370                      4716                                     2695                 19429      11500     7748           1418     449       1704      387       489            161      104       N/A
  Bangladesh             SearoD           14707333                    4484527                    326317                                   44752                1293338    765509    512461         98105    7462      117940    26805     18310          6035     1114      N/A
  Bhutan                 SearoD           70891                       12773                      894                                      511                  3684       2180      1469           269      85        323       73        152            50       32        N/A
  DPR of Korea           SearoD           1704446                     393494                     27545                                    15740                113484     67169     45252          8281     2625      9955      2263      1744           575      371       N/A
  India                  SearoD           127960004                   35361230                   2475286                                  1414449              10198179   6036162   4066541        744177   235859    894639    203327    388144         127932   82519     N/A
  Maldives               SearoD           25984                       4061                       284                                      162                  1171       693       467            85       27        103       23        6              2        1         N/A
  Myanmar                SearoD           3956305                     1213300                    84931                                    48532                349916     207110    139530         25534    8093      30697     6976      9129           3009     1941      N/A
  Nepal                  SearoD           3506023                     832451                     58272                                    33298                240079     142099    95732          17519    5552      21061     4787      5501           1813     1170      N/A
  **WPRO REGION**                                                                                                                                                                                                                                                           
  Australia              WproA            1457527                     32776                      1204                                     385                  17778      10416     8374           841      149       2724      1654      38             7        3         N/A
  Brunei D\'lam          WproA            37385                       899                        65                                       9                    488        286       239            46       3         70        42        3              1        0         N/A
  Japan                  WproA            5430793                     135770                     9504                                     5431                 73642      43148     36251          6634     2103      10150     6163      231            76       49        N/A
  New Zealand            WproA            311974                      7036                       264                                      90                   3816       2236      1800           184      35        583       354       31             6        2         N/A
  Singapore              WproA            230550                      5764                       403                                      231                  3126       1832      1539           282      89        431       262       9              3        2         N/A
  Cambodia               WproB            1491690                     373583                     27150                                    4096                 107741     63771     42699          8162     683       12489     7583      2101           693      140       N/A
  China                  WproB            81595595                    6488544                    454198                                   259542               1871296    1107594   746183         136551   43279     208931    126851    43089          14202    9161      N/A
  Cook Islands           WproB            2096                        210                        15                                       2                    61         36        24             5        0         7         4         0              0        0         N/A
  Fiji                   WproB            89552                       14426                      1051                                     125                  4161       2463      1648           316      21        484       294       30             10       2         N/A
  Kiribati               WproB            9948                        1625                       118                                      18                   469        277       186            35       3         54        33        19             6        1         N/A
  Lao Peop\'s DR         WproB            682861                      212441                     15325                                    3573                 61268      36264     24312          4607     596       7049      4280      1076           355      107       N/A
  Malaysia               WproB            2828151                     285716                     20781                                    2945                 82400      48772     32652          6248     491       9559      5804      199            66       12        N/A
  Marshall Isl.          WproB            5400                        934                        59                                       10                   269        159       106            18       2         32        19        5              2        0         N/A
  Micronesia             WproB            13237                       2620                       118                                      50                   756        447       292            35       8         91        55        23             5        2         N/A
  Mongolia               WproB            296799                      60292                      4389                                     582                  17388      10292     6889           1320     97        2019      1226      332            109      20        N/A
  Nauru                  WproB            1025                        97                         7                                        1                    28         16        11             2        0         3         2         1              0        0         N/A
  Niue                   WproB            152                         15                         1                                        0                    4          3         2              0        0         1         0         0              0        0         N/A
  Palau                  WproB            2046                        211                        12                                       4                    61         36        24             3        1         7         4         0              0        0         N/A
  Papua N. G.            WproB            962437                      166267                     11905                                    3755                 47951      28382     19051          3579     626       5476      3325      2038           672      264       N/A
  Philippines            WproB            11254421                    2428448                    170059                                   96399                700364     414536    279254         51127    16075     78227     47495     8974           2958     1896      N/A
  R. of Korea            WproB            2371820                     249811                     17487                                    9992                 72045      42643     28728          5257     1666      8044      4884      56             18       12        N/A
  Samoa                  WproB            22338                       3377                       245                                      43                   974        576       386            74       7         113       68        7              2        1         N/A
  Solomon Isl.           WproB            79962                       19101                      1381                                     290                  5509       3261      2185           415      48        635       386       59             20       5         N/A
  Tonga                  WproB            13792                       2223                       162                                      19                   641        379       254            49       3         75        45        4              1        0         N/A
  Tuvalu                 WproB            1015                        126                        9                                        2                    36         22        14             3        0         4         3         0              0        0         N/A
  Vanuatu                WproB            33152                       8344                       584                                      334                  2406       1424      960            176      56        269       163       9              3        2         N/A
  Viet Nam               WproB            7185862                     1728193                    124101                                   35174                498411     295003    197920         37310    5865      57086     34660     3553           1171     420       N/A
  **EURO REGION**                                                                                                                                                                                                                                                           
  Andorra                EuroA            4001                        58                         4                                        1                    31         18        15             3        0         9         2         0              0        0         N/A
  Austria                EuroA            386431                      5604                       406                                      78                   3040       1781      1488           283      30        913       186       5              2        0         N/A
  Belgium                EuroA            616259                      8882                       647                                      80                   4817       2823      2356           452      31        1456      296       7              2        0         N/A
  Croatia                EuroA            389100                      5610                       409                                      52                   3043       1783      1488           285      20        919       187       8              2        0         N/A
  Czech Rep.             EuroA            547804                      7892                       575                                      68                   4280       2508      2093           401      26        1294      263       23             7        1         N/A
  Denmark                EuroA            326007                      4413                       168                                      55                   2394       1402      1129           117      21        770       157       5              1        0         N/A
  Estonia                EuroA            78229                       1129                       82                                       12                   613        359       300            57       5         185       38        2              1        0         N/A
  Finland                EuroA            299477                      4314                       314                                      37                   2340       1371      1144           219      14        708       144       7              2        0         N/A
  France                 EuroA            3974436                     53589                      2019                                     534                  29067      17031     13698          1409     207       9391      1910      61             12       3         N/A
  Germany                EuroA            3466740                     49718                      3450                                     516                  26967      15800     13146          2408     200       8192      1666      67             21       4         N/A
  Greece                 EuroA            586137                      8500                       615                                      118                  4610       2701      2257           430      46        1385      282       35             12       3         N/A
  Hungary                EuroA            490804                      7071                       515                                      61                   3835       2247      1875           360      24        1160      236       27             9        1         N/A
  Iceland                EuroA            23511                       339                        25                                       3                    184        108       90             17       1         56        11        0              0        0         N/A
  Ireland                EuroA            358318                      5011                       282                                      53                   2718       1592      1307           197      21        847       172       4              1        0         N/A
  Israel                 EuroA            735243                      10618                      772                                      113                  5759       3375      2818           539      44        1737      353       13             4        1         N/A
  Italy                  EuroA            2901653                     41871                      3047                                     418                  22711      13307     11109          2127     162       6856      1395      30             10       2         N/A
  Luxembourg             EuroA            28783                       389                        15                                       4                    211        124       100            11       1         68        14        0              0        0         N/A
  Malta                  EuroA            19130                       278                        20                                       4                    151        88        74             14       2         45        9         0              0        0         N/A
  Monaco                 EuroA            2001                        29                         2                                        0                    16         9         8              1        0         5         1         0              0        0         N/A
  Netherlands            EuroA            934218                      12528                      435                                      126                  6795       3981      3192           303      49        2208      449       18             3        1         N/A
  Norway                 EuroA            303047                      4085                       150                                      45                   2216       1298      1044           105      17        716       146       3              1        0         N/A
  Poland                 EuroA            1933388                     27852                      2030                                     241                  15107      8851      7388           1417     93        4568      929       126            41       7         N/A
  Portugal               EuroA            516604                      7448                       542                                      69                   4040       2367      1976           379      27        1221      248       3              1        0         N/A
  San Marino             EuroA            1401                        20                         1                                        0                    11         6         5              1        0         3         1         0              0        0         N/A
  Serbia & Montenegro    EuroA            604144                      8747                       634                                      110                  4744       2780      2322           443      43        1428      290       30             10       2         N/A
  Slovakia               EuroA            275895                      3688                       123                                      34                   2000       1172      938            86       13        652       133       35             6        2         N/A
  Slovenia               EuroA            99368                       1433                       104                                      14                   777        455       380            73       5         235       48        2              1        0         N/A
  Spain                  EuroA            2521375                     36353                      2647                                     339                  19718      11553     9644           1848     131       5958      1212      50             16       3         N/A
  Sweden                 EuroA            557426                      7682                       382                                      72                   4167       2441      1989           266      28        1317      268       10             2        1         N/A
  Switzerland            EuroA            376228                      5431                       395                                      56                   2946       1726      1441           276      22        889       181       3              1        0         N/A
  UK                     EuroA            3765820                     50844                      1913                                     560                  27578      16158     13000          1335     217       8898      1810      165            32       10        N/A
  Albania                EuroB            207681                      6230                       436                                      249                  3379       1980      1664           304      96        981       200       66             22       14        N/A
  Bosnia & Herzegovina   EuroB            164958                      4784                       346                                      67                   2595       1520      1270           242      26        780       159       24             8        2         N/A
  Bulgaria               EuroB            373095                      10245                      470                                      122                  5557       3256      2643           328      47        1763      359       219            50       15        N/A
  Georgia                EuroB            256459                      7488                       539                                      143                  4061       2380      1990           376      55        1212      247       108            36       12        N/A
  Romania                EuroB            1079244                     32377                      2266                                     1295                 17561      10290     8645           1582     501       5100      1037      807            266      172       N/A
  FYR Macedonia          EuroB            111863                      3236                       235                                      39                   1755       1029      859            164      15        529       108       10             3        1         N/A
  Turkey                 EuroB            6412702                     172393                     6203                                     1724                 93506      54786     43984          4330     667       30306     6164      2212           408      126       N/A
  Armenia                EuroB            226376                      6661                       475                                      167                  3613       2117      1773           332      65        1070      218       80             26       11        N/A
  Azerbaijan             EuroB            795163                      23855                      1670                                     954                  12939      7581      6369           1166     369       3758      764       1448           477      308       N/A
  Kyrgyzstan             EuroB            595111                      17168                      1250                                     166                  9312       5456      4555           872      64        2812      572       599            197      35        N/A
  Tajikistan             EuroB            870519                      25144                      1828                                     267                  13638      7991      6672           1276     104       4114      837       2097           691      136       N/A
  Turkmenistan           EuroB            505844                      14823                      1062                                     325                  8040       4711      3943           741      126       2391      486       824            271      104       N/A
  Uzbekistan             EuroB            2737750                     82133                      5749                                     3285                 44549      26102     21929          4013     1272      12938     2632      4970           1638     1057      N/A
  Belarus                EuroC            514996                      30900                      2163                                     1236                 16760      9820      8250           1510     479       4868      990       51             17       11        N/A
  Kazakhstan             EuroC            1640953                     94676                      6892                                     914                  51352      30088     25117          4811     354       15510     3155      1408           464      83        N/A
  Latvia                 EuroC            115275                      6673                       484                                      82                   3619       2121      1771           338      32        1090      222       19             6        1         N/A
  Lithuania              EuroC            166177                      9592                       698                                      96                   5203       3048      2545           487      37        1571      319       19             6        1         N/A
  R. of Moldova          EuroC            214693                      12557                      902                                      256                  6811       3991      3339           629      99        2029      413       161            53       19        N/A
  Russian Federation     EuroC            8117113                     487027                     34092                                    19481                264163     154777    130036         23797    7542      76721     15604     1618           533      344       N/A
  Ukraine                EuroC            2376293                     139669                     9980                                     3376                 75756      44387     37167          6966     1307      22460     4568      629            207      87        N/A

ALRI -- acute lower respiratory infection, SP -- *Streptococcus pneumoniae*, Hib -- *Haemophilus influenzae* type B, RSV -- respiratory syncytial virus, FLU -- influenza virus

\*For viral etiologies, N/A indicates that estimates are not available at the national level at this point, due to very little available information and high degree of uncertainty of regional and global estimates.

The 2000 estimate of the proportion of pneumonia episodes that are severe was 8.6% (7.0--13.0%), and was based on 6 studies, all of them from LMIC \[[@R18]\]. The estimate for 2010 is based on 9 studies and brings the estimate for LMIC upward, to 11.5% (8.0--33.0%). In HIC for 2000, we did not have an evidence--based estimate for the proportion of pneumonia episodes in the community that develop into severe cases. In this current analysis, we found 9 more recent studies from HIC that show a much higher estimate of the proportion -- 26.7% (20.0--46.7%). However, many of them come from hospital--based studies, where more severe episodes are likely to be clustered, and a lower threshold for severity is generally applied. Still, an increasing trend in the proportion of severe episodes in LMICs seems consistent with a higher proportion expected in HICs. Nevertheless, in an effort not to overestimate the severe pneumonia burden we elected to use the proportion of pneumonia episodes developing into severe disease from the LMIC in all HIC also.

An analysis of the prevalence of exposure to the 5 main risk factors in the year 2010 in comparison to 2000 shows that the prevalence of malnutrition declined in all LMICs from 26.9% to 21.9%, low birth weight from 15.9% to 8.8%, non--exclusive breastfeeding from 64.4% to 52.6% and solid fuel use from 65.5% to 52.2% \[[@R49],[@R50]\]. The exposure to all of those risk factors fell by 20--30%, which provides plausibility to the finding that our estimate of the incidence of pneumonia fell by 25% between 2000 and 2010 in LMICs. We could not perform a similar comparison with the crowding risk factor, because of the change of the definition of crowding from "5 or more" to "7 or more" residents in the same household between surveys done in 2000 and 2010.

This study also exposed rather dramatic changes in the importance of different etiological agents along the spectrum of pneumonia episode severity. At the level of all incident episodes in a community, RSV is the most common pathogen, present in about 28.8% of all episodes, followed by influenza (17.0%), while SP (adjusted for vaccine use of both Hib and PCV) is estimated to account for only 6.9% of cases and Hib (adjusted for vaccine use) in 2.8% of cases. However, at the level of severe episodes, RSV\'s contribution decreased to 22.6% and influenza to 7.0%, while SP rose to 18.3% and Hib to 4.1%. Bacterial etiologies become even more important in the subgroup of the children who eventually die of the disease, with the dominant causes being SP (32.7%) and Hib (15.7%). Again, both of these estimates account for Hib and PCV vaccine use in 2010.

DISCUSSION
==========

Although there is seemingly more evidence used in this study than there was available in the previous studies of global childhood pneumonia morbidity \[[@R1],[@R18]\], the increase in evidence is only slight: 35 studies in 1990--2010 to estimate global pneumonia incidence, in comparison to 28 studies for the period 1960--2000 \[[@R18]\]. This also means that the studies published between 1990 and 2000 were used to produce both estimates. However, the most recent studies (those published after 2000) are consistently showing a substantially lower incidence of community--based pneumonia than was the case historically, which implies that the burden of morbidity is steadily decreasing. This also suggests that the estimates presented in this paper maybe more closely related to the situation in the year 2000 rather than 2010, because we used the information from the previous two decades in the context of scarcity of information, and the true morbidity figures for 2010 are likely to be even smaller, ie, less than 0.20 e/cy. In addition, the decreasing trend is quite consistent with apparent improvements in risk factor prevalence, as recorded by DHS and MICS \[[@R49],[@R50]\].

With more evidence, the proportion of pneumonia cases that are severe has been revised upward. For HIC, most of these estimates were relevant to children hospitalized for pneumonia, thus clustering the most severe cases, while most studies in LMICs are community--based and encompass a full spectrum of severity. Still, it appears that the increase in the proportion of severe episodes in the LMICs is a valid trend, given the high proportion in HICs (which may reflect increased proportion of parents seeking care and lower threshold for hospitalization). This finding may seem paradoxical (ie, that the proportion of pneumonia that is severe in nature is higher in high income settings that LMIC) and may be explained by a propensity to hospitalize children in HIC or by a faster reduction in pneumonia incidence at the community level than in the incidence of severe pneumonia episodes. We could speculate that improved social, economic and lifestyle conditions in many LMICs over the past decade have a rather major effect on pneumonia incidence in the whole population, while the cases that progress into severe episodes are still clustering in the areas with persistent poverty which are not really enjoying the benefits of economic growth, so it is more difficult to reduce them. If this is true, then the proportional contribution of severe episodes to all pneumonia episodes in the community is set to continue increasing over time, although both the cases of pneumonia in the community and severe cases are being reduced -- but the former is being reduced at a faster pace than the latter.

It is reassuring that the etiological estimates for SP, Hib, RSV and influenza, which were based on entirely different data sets from those that were used for the estimates of pneumonia incidence, severe morbidity and mortality, and which were also conducted independently of each other, are all "fitting" into the envelopes of pneumonia incidence, severe morbidity and pneumonia deaths at the global, regional and (for SP and Hib) also at the national level \[[@R37]--[@R46]\]. At the level of pneumonia incidence, there is likely a multitude of etiological causes that contribute to pneumonia in the community. Therefore, at the global level, the four major pathogens combined explain about 55% of all episodes, according to our computations, but this grows to considerably more among pneumonia deaths \[[@R43]--[@R46]\]. The modeling effort does not reveal whether the unattributed fractions are likely from these four pathogens or from other pathogens. As an example, at the level of severe episodes, it appears that the four pathogens explain nearly 95% of all episodes in Europe and 83% in the Americas, but only 48% in Eastern Mediterranean region and as little as 39% in sub--Saharan Africa. A large ongoing project funded by The Gates Foundation -- "The Pneumonia Etiology Research for Child Health (PERCH)" study -- will try to explain etiology of childhood pneumonia better at the global level \[[@R25]\]. It is a 7--site study in LMICs, coordinated by Johns Hopkins University, to determine the etiology, or causes, of pneumonia, and the first results are expected in the latter part of 2014 \[[@R25]\].

All burden of disease estimates must cope with the issue of uncertainty in the data and the estimates. All the estimates of childhood pneumonia at either global, regional or (especially) national levels are inherently uncertain, for the many reasons mentioned in the beginning of this paper. The evidence to population models remains limited, and the case definitions used across studies are not all the same, yet the estimates are rather robust. What makes them plausible, if not certain, is that they are internally consistent: mutually independent cause--specific etiology estimates "fit" into the "envelopes" of total cases, severe cases and deaths; in addition, case--fatality rates between incident cases and deaths, and severe episodes and deaths, based on our model, resemble those observed in real data. This is all reassuring, but it also needs to be noted that the estimates of uncertainty (presented in Online Supplementary Document[(Online Supplementary Document)](#S1){ref-type="supplementary-material"}) are still probably (substantially) under--estimated. This is because each and every parameter derived from a previous parameter (eg, proportion of all acute lower respiratory infection (ALRI) cases that are SP) has its own uncertainty, as do the estimates of vaccine effectiveness, risk factor odds ratios, rates of vaccine coverage, and all other parameters in the model. We typically expressed only uncertainty related to each specific parameter, without adding the uncertainty of all the previous parameters from which the new estimate has been derived. This makes the whole table in the Online Supplementary Document[(Online Supplementary Document)](#S1){ref-type="supplementary-material"} seem more precise than it actually may be, given that the uncertainties are really large, and only the consistency between different estimates in the much bigger picture is what gives it some credibility with the current amount of evidence. CHERG aims to continue identifying new sources of published and unpublished good quality data and updating these estimates regularly with this new information and so increase the quality of its estimates towards the Millennium Development Goal 4 target in 2015 and well beyond, until preventable childhood diseases are adequately controlled and responded to everywhere in the world \[[@R57],[@R58]\].
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